As your dynamic global partner for end-to-end biopharma services, we help you accelerate the development of novel therapies and get them to the patients who need them most.
Accelerate your path to CDx commercialization with an experienced partner that has the global network and expertise to meet your needs.
Our solid tumor comprehensive genomic profiling (CGP) assays for both tissue and plasma samples are available as central lab services or kitted solutions.
ǂ Forward looking statements are not guaranteed.
1 Centralized testing services performed in Baltimore, MD.
2 Refer to PGDx product insert for intended use statement and country availability.
3 For Research Use Only. Not for diagnostic procedures.
PGDx, now a part of Labcorp, is committed to providing tailored solutions that advance your research and commercialization efforts, from early access to emerging biomarkers to custom data outputs to respective analysis.
Supporting academic and clinical oncologists
We are dedicated to helping remove financial barriers to your research — from providing quick and cost-efficient CGP solutions to exploring collaborative cost sharing.
Our CGP solid tumor assays for both tissue and blood samples are powered by proven bioinformatics and have demonstrated sensitive detection of current and emerging biomarkers as well as complex genomic signatures.
We are committed to your success, providing access to our latest technology innovations and to a team of experts that help you navigate each step of your research project.